Mutations in linker-2 of KLF1 impair expression of membrane transporters and cytoskeletal proteins causing hemolysis.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
15 Aug 2024
Historique:
received: 13 03 2023
accepted: 09 07 2024
medline: 16 8 2024
pubmed: 16 8 2024
entrez: 15 8 2024
Statut: epublish

Résumé

The SP/KLF family of transcription factors harbour three C-terminal C2H2 zinc fingers interspersed by two linkers which confers DNA-binding to a 9-10 bp motif. Mutations in KLF1, the founding member of the family, are common. Missense mutations in linker two result in a mild phenotype. However, when co-inherited with loss-of-function mutations, they result in severe non-spherocytic hemolytic anemia. We generate a mouse model of this disease by crossing Klf1

Identifiants

pubmed: 39147774
doi: 10.1038/s41467-024-50579-4
pii: 10.1038/s41467-024-50579-4
doi:

Substances chimiques

Kruppel-Like Transcription Factors 0
erythroid Kruppel-like factor 0
Cytoskeletal Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7019

Subventions

Organisme : Department of Health | National Health and Medical Research Council (NHMRC)
ID : APP1183556

Informations de copyright

© 2024. The Author(s).

Références

Ravasi, T. et al. Systematic characterization of the zinc-finger-containing proteins in the mouse transcriptome. Genome Res. 13, 1430–1442 (2003).
pubmed: 12819142 pmcid: 403681 doi: 10.1101/gr.949803
Bellefroid, E. J. et al. The human genome contains hundreds of genes coding for finger proteins of the Kruppel type. DNA 8, 377–387 (1989).
Presnell, J. S., Schnitzler, C. E. & Browne, W. E. KLF/SP transcription factor family evolution: expansion, diversification, and innovation in eukaryotes. Genome Biol. Evol. 7, 2289–2309 (2015).
pubmed: 26232396 pmcid: 4558859 doi: 10.1093/gbe/evv141
Zhao, Y. et al. “Stripe” transcription factors provide accessibility to co-binding partners in mammalian genomes. Mol. Cell 82, 3398–3411 e11 (2022).
pubmed: 35863348 doi: 10.1016/j.molcel.2022.06.029
McConnell, B. B. & Yang, V. W. Mammalian Kruppel-like factors in health and diseases. Physiol. Rev. 90, 1337–1381 (2010).
pubmed: 20959618 doi: 10.1152/physrev.00058.2009
Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).
pubmed: 16904174 doi: 10.1016/j.cell.2006.07.024
van Vliet, J. et al. Human KLF17 is a new member of the Sp/KLF family of transcription factors. Genomics 87, 474–482 (2006).
pubmed: 16460907 doi: 10.1016/j.ygeno.2005.12.011
Laity, J. H., Dyson, H. J. & Wright, P. E. DNA-induced alpha-helix capping in conserved linker sequences is a determinant of binding affinity in Cys(2)-His(2) zinc fingers. J. Mol. Biol. 295, 719–727 (2000).
pubmed: 10656784 doi: 10.1006/jmbi.1999.3406
Choo, Y. & Klug, A. A role in DNA binding for the linker sequences of the first three zinc fingers of TFIIIA. Nucleic Acids Res. 21, 3341–3346 (1993).
pubmed: 8346014 pmcid: 331429 doi: 10.1093/nar/21.15.3341
Pavletich, N. P. & Pabo, C. O. Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A. Science 252, 809–817 (1991).
pubmed: 2028256 doi: 10.1126/science.2028256
Miller, I. J. & Bieker, J. J. A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kruppel family of nuclear proteins. Mol. Cell Biol. 13, 2776–2786 (1993).
pubmed: 7682653 pmcid: 359658
Perkins, A. C., Sharpe, A. H. & Orkin, S. H. Lethal beta-thalassaemia in mice lacking the erythroid CACCC- transcription factor EKLF. Nature 375, 318–322 (1995).
pubmed: 7753195 doi: 10.1038/375318a0
Magor, G. W. et al. KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome. Blood 125, 2405–2417 (2015).
pubmed: 25724378 pmcid: 4521397 doi: 10.1182/blood-2014-08-590968
Nuez, B., Michalovich, D., Bygrave, A., Ploemacher, R. & Grosveld, F. Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature 375, 316–318 (1995).
pubmed: 7753194 doi: 10.1038/375316a0
Tallack, M. R. et al. Novel roles for KLF1 in erythropoiesis revealed by mRNA-seq. Genome Res. 22, 2385–2398 (2012).
pubmed: 22835905 pmcid: 3514668 doi: 10.1101/gr.135707.111
Tallack, M. R. et al. A global role for KLF1 in erythropoiesis revealed by ChIP-seq in primary erythroid cells. Genome Res. 20, 1052–1063 (2010).
pubmed: 20508144 pmcid: 2909569 doi: 10.1101/gr.106575.110
Hay, D. et al. Genetic dissection of the alpha-globin super-enhancer in vivo. Nat. Genet. 48, 895–903 (2016).
pubmed: 27376235 pmcid: 5058437 doi: 10.1038/ng.3605
Pilon, A. M. et al. Failure of terminal erythroid differentiation in EKLF-deficient mice is associated with cell cycle perturbation and reduced expression of E2F2. Mol. Cell Biol. 28, 7394–7401 (2008).
pubmed: 18852285 pmcid: 2593440 doi: 10.1128/MCB.01087-08
Gnanapragasam, M. N. et al. EKLF/KLF1-regulated cell cycle exit is essential for erythroblast enucleation. Blood 128, 1631–1641 (2016).
pubmed: 27480112 pmcid: 5034741 doi: 10.1182/blood-2016-03-706671
Viprakasit, V. et al. Mutations in Kruppel-like factor 1 cause transfusion-dependent hemolytic anemia and persistence of embryonic globin gene expression. Blood 123, 1586–1595 (2014).
pubmed: 24443441 doi: 10.1182/blood-2013-09-526087
Huang, J. et al. Compound heterozygosity for KLF1 mutations is associated with microcytic hypochromic anemia and increased fetal hemoglobin. Eur. J. Hum. Genet. 23, 1341–1348 (2015).
pubmed: 25585695 pmcid: 4592085 doi: 10.1038/ejhg.2014.291
Gallienne, A. E., Dreau, H. M., Schuh, A., Old, J. M. & Henderson, S. Ten novel mutations in the erythroid transcription factor KLF1 gene associated with increased fetal hemoglobin levels in adults. Haematologica 97, 340–343 (2012).
pubmed: 22102705 pmcid: 3291586 doi: 10.3324/haematol.2011.055442
Perkins, A. et al. Kruppeling erythropoiesis: an unexpected broad spectrum of human red blood cell disorders due to KLF1 variants. Blood 127, 1856–1862 (2016).
pubmed: 26903544 pmcid: 4832505 doi: 10.1182/blood-2016-01-694331
Sorolla, A. et al. Identification of novel hypomorphic and null mutations in Klf1 derived from a genetic screen for modifiers of alpha-globin transgene variegation. Genomics 105, 116–122 (2015).
pubmed: 25451176 doi: 10.1016/j.ygeno.2014.09.013
Nilson, D. G., Sabatino, D. E., Bodine, D. M. & Gallagher, P. G. Major erythrocyte membrane protein genes in EKLF-deficient mice. Exp. Hematol. 34, 705–712 (2006).
pubmed: 16728274 doi: 10.1016/j.exphem.2006.02.018
Tallack, M. R., Keys, J. R., Humbert, P. O. & Perkins, A. C. EKLF/KLF1 controls cell cycle entry via direct regulation of E2f2. J. Biol. Chem. 284, 20966–20974 (2009).
pubmed: 19457859 pmcid: 2742862 doi: 10.1074/jbc.M109.006346
Gillinder, K. R. et al. Promiscuous DNA-binding of a mutant zinc finger protein corrupts the transcriptome and diminishes cell viability. Nucleic Acids Res. 45, 1130–1143 (2017).
pubmed: 28180284 doi: 10.1093/nar/gkw1014
Perkins, A. C. & Bieker, J. Congenital anemia phenotypes due to KLF1 mutations. J. Pediatr. Hematol. Oncol. 43, e148–e149 (2020).
Planutis, A. et al. Neomorphic effects of the neonatal anemia (Nan-Eklf) mutation contribute to deficits throughout development. Development 144, 430–440 (2017).
pubmed: 28143845 pmcid: 5341802 doi: 10.1242/dev.145656
Ilsley, M. D. et al. Corrupted DNA-binding specificity and ectopic transcription underpin dominant neomorphic mutations in KLF/SP transcription factors. BMC Genomics 20, 417 (2019).
pubmed: 31126231 pmcid: 6534859 doi: 10.1186/s12864-019-5805-z
Kulczynska, K., Bieker, J. J. & Siatecka, M. A Kruppel-like factor 1 (KLF1) Mutation Associated with Severe Congenital Dyserythropoietic Anemia Alters Its DNA-Binding Specificity. Mol. Cell Biol. 40, e00444–19 (2020).
pubmed: 31818881 pmcid: 7020642 doi: 10.1128/MCB.00444-19
Kambouris, M. et al. Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome. Orphanet J. Rare Dis. 9, 80 (2014).
pubmed: 24907849 pmcid: 4070100 doi: 10.1186/1750-1172-9-80
Cordeddu, V. et al. Mutations in ZBTB20 cause Primrose syndrome. Nat. Genet. 46, 815–817 (2014).
pubmed: 25017102 doi: 10.1038/ng.3035
Hodge, D. et al. A global role for EKLF in definitive and primitive erythropoiesis. Blood 107, 3359–3370 (2006).
pubmed: 16380451 pmcid: 1895762 doi: 10.1182/blood-2005-07-2888
Tallack, M. R. & Perkins, A. C. KLF1 directly coordinates almost all aspects of terminal erythroid differentiation. IUBMB Life 62, 886–890 (2010).
pubmed: 21190291 doi: 10.1002/iub.404
Porpiglia, E., Hidalgo, D., Koulnis, M., Tzafriri, A. R. & Socolovsky, M. Stat5 signaling specifies basal versus stress erythropoietic responses through distinct binary and graded dynamic modalities. PLoS Biol. 10, e1001383 (2012).
pubmed: 22969412 pmcid: 3433736 doi: 10.1371/journal.pbio.1001383
Gillinder, K. R. et al. Direct targets of pStat5 signalling in erythropoiesis. PLoS ONE 12, e0180922 (2017).
pubmed: 28732065 pmcid: 5521770 doi: 10.1371/journal.pone.0180922
Montel-Hagen, A. et al. The Glut1 and Glut4 glucose transporters are differentially expressed during perinatal and postnatal erythropoiesis. Blood 112, 4729–4738 (2008).
pubmed: 18796630 doi: 10.1182/blood-2008-05-159269
Nebor, D. et al. Mutant KLF1 in adult anemic nan mice leads to profound transcriptome changes and disordered erythropoiesis. Sci. Rep. 8, 12793 (2018).
pubmed: 30143664 pmcid: 6109071 doi: 10.1038/s41598-018-30839-2
Siatecka, M. et al. Severe anemia in the Nan mutant mouse caused by sequence-selective disruption of erythroid Kruppel-like factor. Proc. Natl Acad. Sci. USA 107, 15151–15156 (2010).
pubmed: 20696915 pmcid: 2930539 doi: 10.1073/pnas.1004996107
Perkins, A. C., Gaensler, K. M. & Orkin, S. H. Silencing of human fetal globin expression is impaired in the absence of the adult beta-globin gene activator protein EKLF. Proc. Natl Acad. Sci. USA 93, 12267–12271 (1996).
pubmed: 8901569 pmcid: 37979 doi: 10.1073/pnas.93.22.12267
Borg, J. et al. Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat. Genet. 42, 801–805 (2010).
pubmed: 20676099 pmcid: 2930131 doi: 10.1038/ng.630
Burdach, J. et al. Regions outside the DNA-binding domain are critical for proper in vivo specificity of an archetypal zinc finger transcription factor. Nucleic Acids Res. 42, 276–289 (2014).
pubmed: 24106088 doi: 10.1093/nar/gkt895
Loft, A. et al. Browning of human adipocytes requires KLF11 and reprogramming of PPARgamma superenhancers. Genes Dev. 29, 7–22 (2015).
pubmed: 25504365 pmcid: 4281566 doi: 10.1101/gad.250829.114
Aksoy, I. et al. Klf4 and Klf5 differentially inhibit mesoderm and endoderm differentiation in embryonic stem cells. Nat. Commun. 5, 3719 (2014).
pubmed: 24770696 doi: 10.1038/ncomms4719
Chen, X. et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133, 1106–1117 (2008).
pubmed: 18555785 doi: 10.1016/j.cell.2008.04.043
Terrados, G. et al. Genome-wide localization and expression profiling establish Sp2 as a sequence-specific transcription factor regulating vitally important genes. Nucleic Acids Res. 40, 7844–7857 (2012).
pubmed: 22684502 pmcid: 3439921 doi: 10.1093/nar/gks544
Khan, A. A. et al. Dematin and adducin provide a novel link between the spectrin cytoskeleton and human erythrocyte membrane by directly interacting with glucose transporter-1. J. Biol. Chem. 283, 14600–14609 (2008).
pubmed: 18347014 pmcid: 2386908 doi: 10.1074/jbc.M707818200
Rungaldier, S., Oberwagner, W., Salzer, U., Csaszar, E. & Prohaska, R. Stomatin interacts with GLUT1/SLC2A1, band 3/SLC4A1, and aquaporin-1 in human erythrocyte membrane domains. Biochim Biophys. Acta 1828, 956–966 (2013).
pubmed: 23219802 pmcid: 3790964 doi: 10.1016/j.bbamem.2012.11.030
Fandos, C. et al. GLUT1 glucose transporter gene transcription is repressed by Sp3. Evidence for a regulatory role of Sp3 during myogenesis. J. Mol. Biol. 294, 103–119 (1999).
pubmed: 10556032 doi: 10.1006/jmbi.1999.3216
Lun, A. T. & Smyth, G. K. csaw: a Bioconductor package for differential binding analysis of ChIP-seq data using sliding windows. Nucleic Acids Res. 44, e45 (2015).
Tepakhan, W. et al. Nine known and five novel mutations in the erythroid transcription factor KLF1 gene and phenotypic expression of fetal hemoglobin in hemoglobin E disorder. Blood Cells Mol. Dis. 59, 85–91 (2016).
pubmed: 27282573 doi: 10.1016/j.bcmd.2016.04.010
Hashimoto, H. et al. Distinctive Klf4 mutants determine preference for DNA methylation status. Nucleic Acids Res. 44, 10177–10185 (2016).
pubmed: 27596594 pmcid: 5137437
Pavletich, N. P. & Pabo, C. O. Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers. Science 261, 1701–1707 (1993).
pubmed: 8378770 doi: 10.1126/science.8378770
Doig, A. J. & Baldwin, R. L. N- and C-capping preferences for all 20 amino acids in alpha-helical peptides. Protein Sci. 4, 1325–1336 (1995).
pubmed: 7670375 pmcid: 2143170 doi: 10.1002/pro.5560040708
Chung, J. et al. The mTORC1/4E-BP pathway coordinates hemoglobin production with L-leucine availability. Sci. Signal 8, ra34 (2015).
pubmed: 25872869 pmcid: 4402725 doi: 10.1126/scisignal.aaa5903
Liu, D. et al. KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of beta-thalassemia. Blood 124, 803–811 (2014).
pubmed: 24829204 pmcid: 4118488 doi: 10.1182/blood-2014-03-561779
Perseu, L. et al. KLF1 gene mutations cause borderline HbA(2). Blood 118, 4454–4458 (2011).
pubmed: 21821711 doi: 10.1182/blood-2011-04-345736
Singleton, B. K., Frayne, J. & Anstee, D. J. Blood group phenotypes resulting from mutations in erythroid transcription factors. Curr. Opin. Hematol. 19, 486–493 (2012).
pubmed: 22954727 doi: 10.1097/MOH.0b013e328358f92e
Arnaud, L. et al. A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia. Am. J. Hum. Genet. 87, 721–727 (2010).
pubmed: 21055716 pmcid: 2978953 doi: 10.1016/j.ajhg.2010.10.010
Lu, Y. et al. Gene disruption of dematin causes precipitous loss of erythrocyte membrane stability and severe hemolytic anemia. Blood 128, 93–103 (2016).
pubmed: 27073223 pmcid: 4937361 doi: 10.1182/blood-2016-01-692251
Flatt, J. F. et al. Stomatin-deficient cryohydrocytosis results from mutations in SLC2A1: a novel form of GLUT1 deficiency syndrome. Blood 118, 5267–5277 (2011).
pubmed: 21791420 doi: 10.1182/blood-2010-12-326645
Oburoglu, L. et al. Glucose and glutamine metabolism regulate human hematopoietic stem cell lineage specification. Cell Stem Cell 15, 169–184 (2014).
pubmed: 24953180 doi: 10.1016/j.stem.2014.06.002
Niihara, Y. et al. A phase 3 trial of l-glutamine in sickle cell disease. N. Engl. J. Med. 379, 226–235 (2018).
pubmed: 30021096 doi: 10.1056/NEJMoa1715971
Clemens, K. R. et al. Relative contributions of the zinc fingers of transcription factor IIIA to the energetics of DNA binding. J. Mol. Biol. 244, 23–35 (1994).
pubmed: 7966319 doi: 10.1006/jmbi.1994.1701
Singleton, B. K., Burton, N. M., Green, C., Brady, R. L. & Anstee, D. J. Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype. Blood 112, 2081–2088 (2008).
pubmed: 18487511 doi: 10.1182/blood-2008-03-145672
Singleton, B. K. et al. Mutations in the second zinc finger of human EKLF reduce promoter affinity but give rise to benign and disease phenotypes. Blood 118, 3137–3145 (2011).
pubmed: 21778342 doi: 10.1182/blood-2011-04-349985
Trapnell, C. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562–578 (2012).
pubmed: 22383036 pmcid: 3334321 doi: 10.1038/nprot.2012.016
Lerdrup, M., Johansen, J. V., Agrawal-Singh, S. & Hansen, K. An interactive environment for agile analysis and visualization of ChIP-sequencing data. Nat. Struct. Mol. Biol. 23, 349–357 (2016).
pubmed: 26926434 doi: 10.1038/nsmb.3180
Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
pubmed: 15264254 doi: 10.1002/jcc.20084
Glogowska, E., Lezon-Geyda, K., Maksimova, Y., Schulz, V. P. & Gallagher, P. G. Mutations in the Gardos channel (KCNN4) are associated with hereditary xerocytosis. Blood 126, 1281–1284 (2015).
pubmed: 26198474 pmcid: 4566808 doi: 10.1182/blood-2015-07-657957
Xue, L., Galdass, M., Gnanapragasam, M. N., Manwani, D. & Bieker, J. J. Extrinsic and intrinsic control by EKLF (KLF1) within a specialized erythroid niche. Development 141, 2245–2254 (2014).
pubmed: 24866116 pmcid: 4034424 doi: 10.1242/dev.103960
Choi, H. S., Lee, E. M., Kim, H. O., Park, M. I. & Baek, E. J. Autonomous control of terminal erythropoiesis via physical interactions among erythroid cells. Stem Cell Res. 10, 442–453 (2013).
pubmed: 23500644 doi: 10.1016/j.scr.2013.02.003
Funnell, A. P. et al. Erythroid Kruppel-like factor directly activates the basic Kruppel-like factor gene in erythroid cells. Mol. Cell Biol. 27, 2777–2790 (2007).
pubmed: 17283065 pmcid: 1899893 doi: 10.1128/MCB.01658-06
Ilsley, M. D. et al. Kruppel-like factors compete for promoters and enhancers to fine-tune transcription. Nucleic Acids Res. 45, 6572–6588 (2017).
pubmed: 28541545 pmcid: 5499887 doi: 10.1093/nar/gkx441
Hattangadi, S. M. et al. Histones to the cytosol: exportin 7 is essential for normal terminal erythroid nuclear maturation. Blood 124, 1931–1940 (2014).
pubmed: 25092175 pmcid: 4168348 doi: 10.1182/blood-2013-11-537761
Kiatpakdee, B. et al. Cholesterol-binding protein TSPO2 coordinates maturation and proliferation of terminally differentiating erythroblasts. J. Biol. Chem. 295, 8048–8063 (2020).
pubmed: 32358067 pmcid: 7278357 doi: 10.1074/jbc.RA119.011679

Auteurs

Stephen Huang (S)

Mater Research Institute - UQ, The University of Queensland, St Lucia, Australia.
School of Biomedical Sciences, The University of Queensland, St Lucia, Australia.

Casie Reed (C)

Australian Centre for Blood Diseases, Monash University, Clayton, Australia.

Melissa Ilsley (M)

Mater Research Institute - UQ, The University of Queensland, St Lucia, Australia.
School of Biomedical Sciences, The University of Queensland, St Lucia, Australia.

Graham Magor (G)

Mater Research Institute - UQ, The University of Queensland, St Lucia, Australia.
Australian Centre for Blood Diseases, Monash University, Clayton, Australia.

Michael Tallack (M)

Mater Research Institute - UQ, The University of Queensland, St Lucia, Australia.

Michael Landsberg (M)

School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Australia.

Helen Mitchell (H)

Australian Centre for Blood Diseases, Monash University, Clayton, Australia.

Kevin Gillinder (K)

Mater Research Institute - UQ, The University of Queensland, St Lucia, Australia.
Australian Centre for Blood Diseases, Monash University, Clayton, Australia.

Andrew Perkins (A)

Mater Research Institute - UQ, The University of Queensland, St Lucia, Australia. Andrew.perkins@monash.edu.
School of Biomedical Sciences, The University of Queensland, St Lucia, Australia. Andrew.perkins@monash.edu.
Australian Centre for Blood Diseases, Monash University, Clayton, Australia. Andrew.perkins@monash.edu.
Department of Haematology, The Alfred Hospital, Melbourne, Australia. Andrew.perkins@monash.edu.
Biodiscovery Institute, Monash University, Clayton, Australia. Andrew.perkins@monash.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH